ConductScience.org, home

Paper41326809

Serotonin receptor 4 in the ventral CA3 regulates agomelatine-induced anxiolytic-like behaviors.

Liu XH and 6 others. Acta Pharmacol Sin, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Serotonin receptor 4 in the ventral CA3 regulates agomelatine-induced anxiolytic-like behaviors. Papers, record 41326809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41326809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serotonin receptor 4 in the ventral CA3 regulates agomelatine-induced anxiolytic-like behaviors.
PubMed
Journal
Acta Pharmacol Sin
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-03-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu XHXiang-Hu
2Naveed MMuhammad
3Hu XYXiao-Yun
4Zhu LLLin-Lin
5Meng FFan
6Zhou QGQi-Gang
7Zhang JJing

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetamidesMajor topic
Anti-Anxiety AgentsMajor topic
AnxietyMajor topic
CA3 Region, HippocampalMajor topic
Animals
Male
Mice
Behavior, Animal
Mice, Inbred C57BL
Stress, Psychological
Restraint, Physical
Naphthalenes

Source PubMed

Download CSV of topics

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136193171Quantifying the global burden of mental disorders and their economic value.EClinicalMedicine2022https://conductscience.org/library/papers/36193171PubMed
234979437Sleep and anxiety: From mechanisms to interventions.Sleep Med Rev2022https://conductscience.org/library/papers/34979437PubMed
333581801Anxiety disorders.Lancet2021https://conductscience.org/library/papers/33581801PubMed
433424664Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.Front Psychiatry2020https://conductscience.org/library/papers/33424664PubMed
529487083Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.Pharmacol Rev2018https://conductscience.org/library/papers/29487083PubMed
634210446Insomnia: Pharmacologic Treatment.Clin Geriatr Med2021https://conductscience.org/library/papers/34210446PubMed
728593281Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.JAMA Psychiatry2017https://conductscience.org/library/papers/28593281PubMed
833713641Diazepam effects on local cortical neural activity during sleep in mice.Biochem Pharmacol2021https://conductscience.org/library/papers/33713641PubMed
926514204MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.Annu Rev Pharmacol Toxicol2016https://conductscience.org/library/papers/26514204PubMed
1034419186Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention.Lancet Psychiatry2021https://conductscience.org/library/papers/34419186PubMed
1124724693Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.Br J Pharmacol2014https://conductscience.org/library/papers/24724693PubMed
1220577266Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.Nat Rev Drug Discov2010https://conductscience.org/library/papers/20577266PubMed
1318794654Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.J Clin Psychopharmacol2008https://conductscience.org/library/papers/18794654PubMed
1424766542Agomelatine in treating generalized anxiety disorder.Expert Opin Investig Drugs2014https://conductscience.org/library/papers/24766542PubMed
1528730851Agomelatine for the treatment of generalized anxiety disorder.Expert Opin Pharmacother2017https://conductscience.org/library/papers/28730851PubMed
1620950634Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.Neuropsychologia2011https://conductscience.org/library/papers/20950634PubMed
1716741211Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder.Am J Psychiatry2006https://conductscience.org/library/papers/16741211PubMed
1824623781Circuit-wide structural and functional measures predict ventromedial prefrontal cortex fear generalization: implications for generalized anxiety disorder.J Neurosci2014https://conductscience.org/library/papers/24623781PubMed
1934916083The impact of stress on the hippocampal spatial code.Trends Neurosci2022https://conductscience.org/library/papers/34916083PubMed
2036680709Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety.Neurosci Bull2023https://conductscience.org/library/papers/36680709PubMed

See all 101 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41326809

GET https://conductscience.org/api/papers/v1/41326809/references?page=2